Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism on EDG-7500 Pipeline [Yahoo! Finance]
Edgewise Therapeutics, Inc. (EWTX)
Company Research
Source: Yahoo! Finance
Edgewise Therapeutics, Inc. is among the best Robinhood stocks TheFly reported on March 17 that JPMorgan increased its price target for EWTX from $34 to $45 while keeping an Overweight rating on the stock. The firm also added EWTX to its Analyst Focus List as a growth opportunity, highlighting optimism around upcoming pipeline catalysts, especially renewed attention on EDG-7500. Anticipation builds for the full 12-week data expected in Q2, which could significantly influence the fundamental outlook for EDG-7500. JPMorgan views the overall setup for EWTX in 2026 as increasingly favorable, reflecting confidence in the company's potential and the opportunities presented by its pipeline developments. Separately, earlier on March 10, Edgewise Therapeutics, Inc. (NASDAQ:EWTX) shared long-term results from its MESA open-label extension study evaluating sevasemten in Becker muscular dystrophy, a condition with no approved treatments. The findings indicate that patients on sevasemten maint
Show less
Read more
Impact Snapshot
Event Time:
EWTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EWTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EWTX alerts
High impacting Edgewise Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
EWTX
News
- Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing RulesPR Newswire
- Why Edgewise Therapeutics Stock Topped the Market on Tuesday [Yahoo! Finance]Yahoo! Finance
- Edgewise Therapeutics (EWTX) had its price target raised by JPMorgan Chase & Co. from $34.00 to $45.00. They now have an "overweight" rating on the stock.MarketBeat
- Edgewise Therapeutics (EWTX) had its "outperform" rating reaffirmed by Wedbush. They now have a $32.00 price target on the stock.MarketBeat
- Why Edgewise Therapeutics (EWTX) Is Up 6.4% After Long-Term Sevasemten Becker Data - And What's Next [Yahoo! Finance]Yahoo! Finance
EWTX
Earnings
- 2/26/26 - Miss
EWTX
Sec Filings
- 4/3/26 - Form 4
- 4/2/26 - Form 4
- 3/31/26 - Form 4
- EWTX's page on the SEC website